Categories
Archives
- December 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
Meta
Links
POSTTRAUMATIC STRESS DISORDER…
02/07/09
POST-TRAUMATIC STRESS DISORDER
Post-traumatic stress disorder (PTSD) is the only psychiatric condition for which we claim to know the precise environmental cause. Although it is an ancient, very common condition, it is newly understood. Our knowledge of the way it develops is helping us understand how the brain works, both in health and in disease. Many forms of treatment are available, but so far, there is no best treatment. It is likely that many people will be affected by PTSD in the aftermath of the terrorist attacks in the United States and elsewhere. These events certainly qualify as traumas [significant, upsetting experiences or events that may precipitate or aggravate a mental disorder].
History. The disorder now known as PTSD was first described in wartime about 300 years ago. It has had many colorful names, such as "nostalgia" (Civil War), "shell shock" (World War I), and "traumatic war neurosis" (World War II). Other names have included "soldier's heart" and "railway spine." The term "post-traumatic stress disorder" was coined after the Vietnam War and formalized in 1980 with its inclusion in the definitive Diagnostic and Statistical Manual of Mental Disorders, Third Edition.
The new term was more than just a clever phrase; it reflected a change in the thinking about the how the disorder developed. Previously, childhood developmental problems were thought to be the basis for the symptoms. Now, current research and changing attitudes about mental illnesses were leading to a different conclusion-that lasting symptoms such as those in PTSD could result from exposure to severe trauma and intensely stressful situations. This newer model of the disorder was welcomed by many patients and families.
Epidemiology. At some point during their lifetime, more than 50 percent of the U.S. population experiences a trauma severe enough to cause PTSD, and almost 8 percent of the population is actually affected by the disorder. These figures show that almost 20 percent of people exposed to a trauma will go on to develop PTSD. Almost 4 percent of the U.S. population experiences PTSD in any given year.
We cannot predict with certainty who will develop PTSD after exposure to a severe trauma, but the some of the risk factors are prior traumatic experiences (especially in childhood); preexisting psychiatric disorders; poor social supports, and a family history of psychiatric disorders. A person's proximity to the traumatic event and the severity of the event are important. Not all traumatic events are equally likely to result in PTSD; for example, being raped is far more predisposing than is witnessing a killing, being seriously injured, or being caught up in a natural disaster. Being held hostage or being kidnapped are among the events most likely to cause the disorder. Women are twice as likely as men to have it.
Diagnosis and Symptoms. A diagnosis of PTSD is based on specific symptoms that begin after a person is exposed to a traumatic event. Here, the term "exposed" means that the person both
The person then must develop symptoms from each of the following three clusters:
The symptoms may begin immediately after a traumatic event, and they are considered normal for as long as a month afterwards. If the symptoms last three months or longer, the disorder is considered chronic; if they last less than three months, acute. If PTSD symptoms emerge months or years after a trauma, the disorder is called delayed-onset PTSD.
Treatment. We have a rich array of insufficiently tested treatments for PTSD. The disorder has generated a great deal of interest and study by psychiatrists and other health-care workers, perhaps because it causes so much suffering and its symptoms are dramatic. A tremendous amount of research on PTSD is under way, and we are beginning to get data on the effectiveness of various treatments. Because PTSD encompasses a variety of symptoms, and each patient has his or her unique mixture, no single treatment is likely to help everyone who has it.
Below are some guidelines that should help people decide what to do about their symptoms.
Conclusion. Not only is PTSD a frightening and disabling disorder, it is also quite common. As we study this disorder, we become more able to help people who are suffering from it. Unfortunately, the tendency to avoid the reexperiencing symptoms and associated hyperarousal often keeps a person from getting help. Although there is no best treatment for PTSD, many available good and helpful treatments are evolving.
By David M. Goldstein, M.D.
Director, Mood Disorders Program
Clinical Professor of Psychiatry
Director, Psychopharmacologic Research
Georgetown University School of Medicine
Washington, DC
References
American Psychiatric Association, Committee on Nomenclature and Statistics. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Revised. Washington: American Psychiatric Association, 1994.
Kessler, Ronald C., et al. Posttraumatic Stress Disorder in the National Comorbidity Survey. Archives of General Psychiatry 52 (Dec.), 1995.
Shalev, Arieh Y., et al. Treatment of Posttraumatic Stress Disorder: A Review. Psychosomatic Medicine 58: 165-182, 1996.
Foa, Edna B., et al. (eds.) Effective Treatments for PTSD. New York: Guilford Press, 2000.
International Society for Traumatic Stress Studies 60 Revere Drive, Suite 500 Northbrook IL 60062 www.ISTSS.org Tel: 847-480-9028
________________________
Reprinted from Smooth Sailing, Fall 2001, pages 1-3
Smooth Sailing, the quarterly newsletter of the Depression and Related Affective Disorders Association (DRADA)
DRADA, Meyer 3-181, 600 North Wolfe Street, Baltimore, MD 21287-7381
410-955-4647 or 202-955-5800
drada@jhmi.edu
www.hopkinsmedicine.org/drada
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL